• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

穆勒氏提取物对非酒精性脂肪性肝病的疗效及作用机制

Efficacy and Mechanism of Müll. Arg. Extract on Nonalcoholic Fatty Liver Disease.

作者信息

Lin Daobin, Ding Yi, Cheng Yabo, Chen Yubin, Tang Yunting, Wu Xiaowen, Cheng Yawei

机构信息

Department of Cardiology, Hainan Provincial Hospital of Traditional Chinese Medicine, Haikou 570293, China.

Department of Disease Prevention, Hainan Provincial Hospital of Traditional Chinese Medicine, Haikou 570293, China.

出版信息

Evid Based Complement Alternat Med. 2022 Apr 28;2022:4897463. doi: 10.1155/2022/4897463. eCollection 2022.

DOI:10.1155/2022/4897463
PMID:35529918
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9071860/
Abstract

Nonalcoholic fatty liver disease (NAFLD) is currently the major cause of chronic liver disease globally. To observe the sedative effect of extract (MFE) on NAFLD and the potential molecular mechanism, a high-fat diet (HFD) was used to induce NAFLD in rats for 8 weeks. Rats were orally given MFE (1.7 g/kg, 2.5 g/kg, and 3.3 g/kg) every day. Serum and liver biochemical indexes were detected. 16S rDNA sequencing was performed to test the changes in the gut microbiota. Mass spectrometry was used to analyze the changes in blood and liver metabolites and to perform a joint analysis of differential flora and differential metabolites. The results showed that MFE alleviated liver injury and decreased hepatic lipids content. ELISA analysis certificated that MFE reduced inflammation levels in rats fed with HFD. Compared to HFD rats with a normal diet, MFE significantly changed the overall structure of the intestinal flora and the composition of the intestinal microbes destroyed by HFD. In addition, MFE changes the metabolic levels of lipids and proteins in HFD rats. In conclusion, MFE effectively treated NAFLD and significantly improved the overall structure and intestinal microbial composition of the intestinal microbiota. The abundance of and increased significantly in the partridge tea treatment group.

摘要

非酒精性脂肪性肝病(NAFLD)目前是全球慢性肝病的主要原因。为观察提取物(MFE)对NAFLD的镇静作用及潜在分子机制,采用高脂饮食(HFD)诱导大鼠发生NAFLD 8周。大鼠每天口服给予MFE(1.7 g/kg、2.5 g/kg和3.3 g/kg)。检测血清和肝脏生化指标。进行16S rDNA测序以检测肠道微生物群的变化。采用质谱法分析血液和肝脏代谢产物的变化,并对差异菌群和差异代谢产物进行联合分析。结果表明,MFE减轻了肝损伤并降低了肝脏脂质含量。ELISA分析证实,MFE降低了高脂饮食喂养大鼠的炎症水平。与正常饮食的HFD大鼠相比,MFE显著改变了肠道菌群的整体结构以及被HFD破坏的肠道微生物组成。此外,MFE改变了HFD大鼠的脂质和蛋白质代谢水平。总之,MFE有效治疗了NAFLD,并显著改善了肠道微生物群的整体结构和肠道微生物组成。鹧鸪茶治疗组中[具体菌种名称未给出]和[具体菌种名称未给出]的丰度显著增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda3/9071860/3a94405fa85f/ECAM2022-4897463.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda3/9071860/adfb16bc818e/ECAM2022-4897463.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda3/9071860/be5e5b9546f4/ECAM2022-4897463.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda3/9071860/ece1bd0e10ce/ECAM2022-4897463.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda3/9071860/9da74a5fe859/ECAM2022-4897463.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda3/9071860/6ef03a67780f/ECAM2022-4897463.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda3/9071860/3a94405fa85f/ECAM2022-4897463.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda3/9071860/adfb16bc818e/ECAM2022-4897463.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda3/9071860/be5e5b9546f4/ECAM2022-4897463.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda3/9071860/ece1bd0e10ce/ECAM2022-4897463.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda3/9071860/9da74a5fe859/ECAM2022-4897463.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda3/9071860/6ef03a67780f/ECAM2022-4897463.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda3/9071860/3a94405fa85f/ECAM2022-4897463.006.jpg

相似文献

1
Efficacy and Mechanism of Müll. Arg. Extract on Nonalcoholic Fatty Liver Disease.穆勒氏提取物对非酒精性脂肪性肝病的疗效及作用机制
Evid Based Complement Alternat Med. 2022 Apr 28;2022:4897463. doi: 10.1155/2022/4897463. eCollection 2022.
2
Qinghua Fang inhibits high-fat diet-induced non-alcoholic fatty liver disease by modulating gut microbiota.清华方通过调节肠道微生物群抑制高脂饮食诱导的非酒精性脂肪性肝病。
Ann Palliat Med. 2021 Mar;10(3):3219-3234. doi: 10.21037/apm-21-448.
3
Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats.参令白术散对高脂饮食诱导的非酒精性脂肪肝大鼠肠道微生物群的影响。
Biomed Pharmacother. 2018 Jun;102:1025-1036. doi: 10.1016/j.biopha.2018.03.158. Epub 2018 Apr 5.
4
Probiotics Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats via Gut Microbiota/FXR/FGF15 Signaling Pathway.益生菌通过肠道微生物群/FXR/FGF15 信号通路缓解高脂饮食喂养大鼠的非酒精性脂肪性肝病。
J Immunol Res. 2021 Aug 17;2021:2264737. doi: 10.1155/2021/2264737. eCollection 2021.
5
Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.用白藜芦醇靶向肠道微生物群:管理肝脂肪变性的新证据的例证。
J Nutr Biochem. 2020 Jul;81:108363. doi: 10.1016/j.jnutbio.2020.108363. Epub 2020 Feb 27.
6
Hepatoprotective Effects of on Nonalcoholic Fatty Liver Disease Induced by High-Fat Diet in Mice: An Integrated Gut Microbiota and Metabolomic Analysis.基于肠道微生物群和代谢组学分析的 对高脂饮食诱导的小鼠非酒精性脂肪肝的肝保护作用
Molecules. 2022 May 14;27(10):3148. doi: 10.3390/molecules27103148.
7
Amelioration of Intestinal Barrier Dysfunction by Berberine in the Treatment of Nonalcoholic Fatty Liver Disease in Rats.黄连素对大鼠非酒精性脂肪性肝病肠道屏障功能障碍的改善作用
Pharmacogn Mag. 2017 Oct-Dec;13(52):677-682. doi: 10.4103/pm.pm_584_16. Epub 2017 Nov 13.
8
Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.回肠胆汁酸转运蛋白抑制剂通过改善非酒精性脂肪性肝病模型小鼠肠道微生物失调改善肝脂肪变性。
mBio. 2021 Aug 31;12(4):e0115521. doi: 10.1128/mBio.01155-21. Epub 2021 Jul 6.
9
Microbial Intervention as a Novel Target in Treatment of Non-Alcoholic Fatty Liver Disease Progression.微生物干预作为治疗非酒精性脂肪性肝病进展的新靶点。
Cell Physiol Biochem. 2018;51(5):2123-2135. doi: 10.1159/000495830. Epub 2018 Dec 6.
10
Liraglutide Attenuates Nonalcoholic Fatty Liver Disease by Modulating Gut Microbiota in Rats Administered a High-Fat Diet.利拉鲁肽通过调节高脂肪饮食大鼠的肠道微生物群来减轻非酒精性脂肪肝病。
Biomed Res Int. 2020 Feb 18;2020:2947549. doi: 10.1155/2020/2947549. eCollection 2020.

引用本文的文献

1
Effects of mallotus furetianus extract on CYP3A activities in rats.毛桐提取物对大鼠CYP3A活性的影响。
Sci Rep. 2025 May 27;15(1):18530. doi: 10.1038/s41598-025-02193-7.
2
A Scoping Review on Hepatoprotective Mechanism of Herbal Preparations through Gut Microbiota Modulation.通过调节肠道菌群对草药制剂肝脏保护机制的范围综述
Curr Issues Mol Biol. 2024 Oct 16;46(10):11460-11502. doi: 10.3390/cimb46100682.
3
Aroma Difference Analysis of Partridge Tea () with Different Drying Treatments Based on HS-SPME-GC-MS Technique.

本文引用的文献

1
Association between Pb, Cd, and Hg Exposure and Liver Injury among Korean Adults.韩国成年人铅、镉和汞暴露与肝损伤的关系。
Int J Environ Res Public Health. 2021 Jun 24;18(13):6783. doi: 10.3390/ijerph18136783.
2
Microbiota, Fiber, and NAFLD: Is There Any Connection?微生物群、膳食纤维与非酒精性脂肪性肝病:它们之间有联系吗?
Nutrients. 2020 Oct 12;12(10):3100. doi: 10.3390/nu12103100.
3
Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?理解非酒精性脂肪性肝病发病机制中的脂毒性:CD36 是关键驱动因素吗?
基于 HS-SPME-GC-MS 技术的不同干燥处理对雉鸡茶香气差异分析。
Molecules. 2023 Sep 27;28(19):6836. doi: 10.3390/molecules28196836.
4
Male zooid extracts of ameliorates non-alcoholic fatty liver disease and intestinal dysbacteriosis in mice induced by a high-fat diet.雄虫提取物可改善高脂饮食诱导的小鼠非酒精性脂肪性肝病和肠道菌群失调。
Front Cell Infect Microbiol. 2022 Oct 28;12:1059647. doi: 10.3389/fcimb.2022.1059647. eCollection 2022.
Cell Death Dis. 2020 Sep 25;11(9):802. doi: 10.1038/s41419-020-03003-w.
4
Gut-Pancreas-Liver Axis as a Target for Treatment of NAFLD/NASH.肠-胰-肝轴作为治疗非酒精性脂肪性肝病/非酒精性脂肪性肝炎的靶点。
Int J Mol Sci. 2020 Aug 13;21(16):5820. doi: 10.3390/ijms21165820.
5
extract protects against ethanol-induced liver injury via the activation of the cAMP-PKA pathway.提取物通过激活cAMP-PKA途径预防乙醇诱导的肝损伤。
Food Sci Nutr. 2020 Jun 10;8(7):3936-3946. doi: 10.1002/fsn3.1709. eCollection 2020 Jul.
6
Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications.非酒精性脂肪性肝病发病机制中的肠道微生物群代谢产物及治疗意义。
Int J Mol Sci. 2020 Jul 23;21(15):5214. doi: 10.3390/ijms21155214.
7
From NAFLD to MAFLD: a "redefining" moment for fatty liver disease.从非酒精性脂肪性肝病到代谢相关脂肪性肝病:脂肪性肝病的一个“重新定义”时刻。
Chin Med J (Engl). 2020 Oct 5;133(19):2271-2273. doi: 10.1097/CM9.0000000000000981.
8
The Molecular and Mechanistic Insights Based on Gut-Liver Axis: Nutritional Target for Non-Alcoholic Fatty Liver Disease (NAFLD) Improvement.基于肠-肝轴的分子和机制见解:改善非酒精性脂肪性肝病(NAFLD)的营养靶点。
Int J Mol Sci. 2020 Apr 26;21(9):3066. doi: 10.3390/ijms21093066.
9
Nutrition and Genetics in NAFLD: The Perfect Binomium.非酒精性脂肪性肝病的营养与遗传学:完美的二联体。
Int J Mol Sci. 2020 Apr 23;21(8):2986. doi: 10.3390/ijms21082986.
10
Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders.肠道微生物群与人类非酒精性脂肪性肝病:从代谢紊乱中解析微生物特征。
Nat Rev Gastroenterol Hepatol. 2020 May;17(5):279-297. doi: 10.1038/s41575-020-0269-9. Epub 2020 Mar 9.